Jeff Liter, CEO of Luminary Therapeutics, discusses the importance of demonstrating clinical evidence at the JP Morgan Healthcare Conference.
Jeff Liter
Advertisement
Articles by Jeff Liter
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Wegovy HD Injectable Under Accelerated Approval
2
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
3
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5